Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Smith & Wesson Brands Acquires Savage Arms for $160 Million

Smith & Wesson Brands said it has acquired Savage Arms in a deal valued at $160 million, combining two long-established U.S. firearms makers and immediately expanding Smith & Wesson’s hunting business.

Savage generated about $160 million in net sales over the 12 months ended Sept. 30, 2026. Smith & Wesson said the transaction is expected to add about $18 million of incremental EBITDA on a full-year basis, with further upside after synergies are realized.

The company said the deal will be immediately accretive to fully diluted earnings per share by about $0.04 for the remainder of fiscal 2027. On a full-year basis, it expects accretion of $0.07 per share, rising to about $0.10 per share after initial synergies.

Smith & Wesson said it paid for Savage with a mix of stock and cash: about 9 million shares of its common stock, valued at $13.62 per share, plus $37.5 million in cash. The transaction implies a purchase price of about 7.9 times Savage’s adjusted EBITDA, including expected initial annual run-rate synergies of $2.5 million.

Following the closing, JDH Capital owns 16.7% of Smith & Wesson’s outstanding common stock. JDH also received a board seat, bringing the Smith & Wesson board to seven directors.

Smith & Wesson said the combined company is carrying a pro forma net leverage ratio of 1.16. As a result of these announcements, the company's shares have moved 0.0% on the market, and are now trading at a price of $14.78. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS